The results indicated that both APCP and the anti-CD73 moAb significantly inhibited migration of H2228 and A549 cells, in line with previous observations on breast cancer cells, characterized by inhibition of both tumor growth and metastasis [55,58,59]. This evidence concerns the gene NT5E and breast carcinoma.